GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Alexza Pharmaceuticals, Inc. (ALXA) [hlAlert]

Rating:
Overweight
ALXA
down 74.51 %

Alexza Pharmaceuticals, Inc. (ALXA) upgraded to Overweight by Piper Jaffray

Posted on: Wednesday,  Apr 3, 2013  8:25 AM ET by Piper Jaffray

Piper Jaffray rated Overweight Alexza Pharmaceuticals, Inc. (NASDAQ: ALXA) on 04/03/2013, when the stock price was $4.63. Since
then, Alexza Pharmaceuticals, Inc. has lost 74.51% as of 08/27/2015's recent price of $1.18.
If you would have followed this Piper Jaffray's recommendation on ALXA, you would have lost 74.51% of your investment in 876 days.

Alexza Pharmaceuticals is an emerging pharmaceutical company focused on the development and commercialization of novel, proprietary products for the treatment of acute and intermittent conditions. The Company's technology, the Staccato system, vaporizes unformulated drug to form a condensation aerosol that allows rapid systemic drug delivery through deep lung inhalation. The drug is quickly absorbed through the lungs into the bloodstream, providing speed of therapeutic onset that is comparable to intravenous administration, but with greater ease, patient comfort and convenience.

At Piper Jaffray, we understand there’s no substitute for relevant and timely research. That's why we provide: * fundamental and technical research * value-added investment ideas * market analysis With the information our research team provides, you’ll make better and more informed decisions for your portfolio.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
4/3/2013 8:25 AM Buy
None
4.63
as of 12/13/2013
1 Week down  -4.96 %
1 Month down  -0.64 %
3 Months down  -12.90 %
1 YTD down  -0.86 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/4/2013 8:25 AM Hold
None
4.96

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy